NFKB1 and autoimmune disease: In addition, a previous study suggested that IL‐6 or TNF‐α‐activated NF‐κB p65 could bind to miR‐34a promoter and up‐regulate its transcription, which could serve as a novel mechanistic and therapeutic insight into autoimmune disease progression.8